Biomarker testing strategies in non-small cell lung cancer in the real-world setting: analysis of methods in the Prospective Central Lung Cancer Biomarker Registry (LungPath) from the Spanish Society of Pathology (SEAP)

Conclusions
The real-world evidence obtained from LungPath shows the effort of Spanish hospitals in performing biomarker determination in NSCLC with different methodologies despite that next-generation sequencing (NGS) utilisation in the year of the analysis was low. Biomarker determination results could be optimised with the incorporation of sequencing methods such as NGS in pathology departments.

Source: Journal of Clinical Pathology - April 19, 2023 Category: Pathology Authors: Martin-Lopez, J., Rojo, F., Martinez-Pozo, A., Hernandez-Iglesias, T., Carcedo, D., de Alda, L. R., Garcia, J. F., Salas, C. Tags: Open access Original research Source Type: research